Abhi (@Simpleguy0322) header
Abhi (@Simpleguy0322) profile picture

Intezzar hamesha rahega,bas ab aawaz nahi dege

Ujjain
Joined February 2015
Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)Photo by Abhi (@Simpleguy0322)
Abhi retweeted
27
798
44
3,477
69,857
15
436
34
1,969
42,172
1
82
8
452
6,726
4
77
5
578
8,281
Nearly every child diagnosed with a cancer known as diffuse midline glioma dies within a year. Engineered immune cells just wiped it out in mice. Scientists at UC San Francisco engineered CAR-T cells, immune cells taken from a patient and reprogrammed to hunt cancer, with a clever safety switch. The cells carry a sensor for brevican, a protein found only in the brain, so they stay quiet in the blood and spleen and only arm themselves to attack tumor proteins once they reach brain tissue. The team tested these "B-SYNC" cells against diffuse midline glioma, or DMG, a childhood cancer that grows into the brainstem. In two mouse models carrying human DMG tumors, the treatment eliminated the cancer in every treated mouse, while standard CAR-T cells could not control it. The study was published in Science Translational Medicine. DMG is one of the cruelest cancers in medicine. It grows in the part of the brain that controls breathing, heartbeat and swallowing, so surgeons can't remove it, and nearly all children diagnosed die within a year. The engineered cells were still working more than 70 days later, and when the researchers put tumor cells back into the mice about seven weeks after treatment, every one of them rejected the cancer. That said, these results come from mice carrying human tumors, and many treatments that work in mice fail in children. Also, the cells still need to be shown safe in people. But the team is already working toward a trial at UCSF Health that could begin as early as April 2027. source: Lakshmanachetty, S., ... & Okada, H. (2026). Brain-sensing synNotch–CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models. Science Translational Medicine.
1
34
2
122
4,626
29
1,549
42
12,890
125,815
16
716
30
3,940
67,677
6
401
17
2,310
45,094
7
245
7
1,722
45,942
14
326
9
1,584
25,784
38
680
58
2,597
57,783
Abhi retweeted
22
633
16
3,356
75,540
the thought of growing old without a companion, a chosen family or a support system should scare the sh*t out of more gay men RIGHT NOW
6
7
6
116
4,918
Abhi retweeted
I wish more gay men understood that intimacy doesn't always have to end in sex.
29
41
6
391
13,917
Abhi retweeted
50
737
43
4,161
80,565
7
149
14
873
22,233
21
318
15
1,720
24,986
2
287
13
1,817
45,310
Abhi retweeted
Dear November.
18
380
29
1,670
30,280